Blueprint for an Innovation Economy in Florida Research as Economic Foundation | Page 24

EXHIBITS EXHIB AxoGen ABBREVIATED TIMELINE Pre-Com p any - R&D Predominently NIH Funded. Outcome: Key Basic Discoveries Governing Nerve Cell Regeneration J of Neuroscience, K CA, Muir D, et. J of Neuroscience, J Zuo, D Muir, et.al. *J Cell Biology, Muir D, Engvall E, et.al. *J Neurobiology, Zuo J, Muir D, et.al. National Institute of Health, Muir D, Grant $750K, 5 YR Molecluar Cell Neuroscience, Ferguson Exp Neurology, Zuo J Muir D, et.al. *J of Neuroscience, Krekoski CA, Muir D, et.al. National Institute of Health, Muir D. Grant $1.5M, 5 YR AxoG $700K UF Files Patent *J Grooms, J Engels Found AxoGen, Lisc of UF Tech Two Rounds, Four $30.1M Equity *Note, AxoGen funds many other research activites not shown here. Grant funding here is limited to those made to the principle investigator whose licensed technology helped create the company. 22 Pre-Revenu